SANTEN PHARMACEUTICAL CO.,LTD.

4536 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥1,725.00
-1.15%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Low debt: debt-to-equity of 0.43.
  • Comfortable interest cover: operating profit covers interest about 24 times.
  • Return on equity is moderate at 12.8%.
  • Return on capital employed is moderate at 13.2%.
  • Net profit margin is 12.8%.
  • Current assets comfortably cover current liabilities (current ratio 3.83).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Sales growth has been slow over five years (about 2% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.28

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥5,550億
Current Price¥ 1,725.00
High / Low¥ 2,254.00 / 1,458.00
Stock P/E15.151515
Book Value¥ 394.39
Dividend Yield2.18%
ROCE13.16%
ROE12.80%
Debt to Equity0.43
Current Ratio3.83
P/B Ratio1.8452257
EPS¥ 114.04
PAT Margin12.81%
ICR23.97
Compounded Sales Growth
10 Years —
5 Years 2.30%
3 Years —
TTM —
Compounded Profit Growth
10 Years —
5 Years 8.25%
3 Years —
TTM —
Stock Price CAGR
10 Years —
5 Years —
3 Years —
1 Year —
Return on Equity
10 Years —
5 Years —
3 Years —
Last Year 12.80%
Educational data only. Not a recommendation to buy, sell or hold any security.